This cohort study uses health plan data to investigate whether recombinant zoster vaccination is associated with a reduced risk of postherpetic neuralgia or zoster ophthalmicus.
No takes yet. Share an insight, caveat, or question.
Zerbo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: